The Sheffield MND Care Centre receives >1200 patient visits annually including 120 new referrals. We offer multi-disciplinary care and support to patients and carers living with Motor Neuron Disorders (MND) from across the South Yorkshire region and the whole of the UK.
Sheffield is a major site for clinical trials of neuroprotective therapies, including genetic therapies and studies to improve symptom management and quality of life for people living with MND. As part of the Sheffield Institute for Translational Neuroscience (SITraN) we are positioned to take preclinical laboratory findings and translational interventions forward into clinical evaluation for patient benefit. SITraN has >220 researchers working on disease biology, genetic subclassification and drug discovery for neurodegenerative diseases.
The Queen’s Anniversary Prize for Higher Education 2019 was awarded to the University of Sheffield for improving outcomes for neurodegenerative diseases, highlighting the HeadUp collar for neck weakness, genetic therapy research and progress in biomarkers for MND trials emerging from our programmes.